報(bào)告題目: Impact of early-life chemical exposures and gut microbiome on future health outcomes

報(bào)告人：Matej Ore?i? 教授芬蘭University of Turku

報(bào)告時(shí)間：2025年11月11日 9點(diǎn)30

報(bào)告地點(diǎn)：南京中醫(yī)藥大學(xué)仙林校區(qū)圖書(shū)館514（時(shí)珍學(xué)術(shù)報(bào)告廳）

主持人：?jiǎn)芜M(jìn)軍 教授

報(bào)告人簡(jiǎn)介：Professor Matej Ore?i? holds a PhD in biophysics from Cornell University (1999; Ithaca, NY, USA). He is professor of medicine, with specialization in systems medicine at ?rebro University (Sweden; since 2020) and a professor of biochemistry (metabolomics) at the University of Turku (Finland; since 2024). As of 2025, he is also SciLifeLab group leader (Sweden). Professor Ore?i?’s main research areas include exposomics and metabolomics applications in biomedical research and systems medicine. He is particularly interested in the identification of environmental exposures (exposome) and disease processes associated with different metabolic phenotypes and the underlying mechanisms linking these processes with the development of specific disorders or their co-morbidities. Prof. Ore?i? also initiated the popular MZmine open-source project, which led to the development and release of popular software for metabolomics data processing. As of 2016, he was made a Lifetime Honorary Fellow of the Metabolomics Society. Professor Ore?i? co-authored 340 peer reviewed publications, 156 as first or last author (incl. shared authorships and correspondences), with h-index of 112 (Google Scholar).

兒童健康與中醫(yī)藥省高校重點(diǎn)實(shí)驗(yàn)室